Results 141 to 150 of about 49,377 (194)

Impact of the COVID-19 pandemic on invasive pneumococcal disease in American Indian communities in the Southwest US. [PDF]

J Med Microbiol
Sutcliffe CG, Littlepage S, Yazzie D, Brasinikas G, Christensen L, Damon S, Denny E, Dixon SL, Grant LR, Harker-Jones M, McAuley J, Montanez P, Parker D, Reasonover A, Rice A, Roessler K, Romancito E, Salabye C, Sergent VM, Simons-Petrusa B, Tenequer V, Thompson P, Tsingine M, Weatherholtz RC, Hammitt LL.   +24 more
europepmc   +1 more source

Molecular characterization and antimicrobial resistance of <i>Streptococcus pneumoniae</i> isolated from adult patients with invasive pneumococcal disease in northern Japan, 2017-2023. [PDF]

IJID Reg
Kawaguchiya M, Aung MS, Urushibara N, Ohashi N, Kobayashi N, Kudo K, Ito M, Kobayashi N.   +7 more
europepmc   +1 more source

Changing Landscape of Invasive Pneumococcal Disease Serotypes and Antimicrobial Resistance Following Pneumococcal Conjugate Vaccine Introduction in the Middle East and North Africa Region: A Systematic Review. [PDF]

Vaccines (Basel)
El Zein Z, Nasser M, Boutros CF, Tfaily N, Reslan L, Faour K, Merhi S, Damaj S, Moumneh MB, Bou Dargham T, Youssef N, Haj M, Bou Karroum S, Khafaja S, Assaf Casals A, Chamseddine S, Hneiny L, Dbaibo GS.   +17 more
europepmc   +1 more source

Invasive pneumococcal disease surveillance in Canada, 2021-2022. [PDF]

Can Commun Dis Rep
Griffith A, Golden AR, Lefebvre B, McGeer A, Tyrrell GJ, Zhanel GG, Kus JV, Hoang L, Minion J, Van Caeseele P, Smadi H, Haldane D, Yu Y, Ding X, Steven L, McFadzen J, Franklin K, Martin I.   +17 more
europepmc   +1 more source

Comparative Immune Responses of Patients with Chronic Pulmonary Diseases during the 2-Year Period after Pneumococcal Vaccination

, 2006
Meng Chen, Yuki Hisatomi, Akitsugu Furumoto, Kenji Kawakami, Hironori Masaki, Tsuyoshi Nagatake, Yoshiko Sueyasu, Tomoaki Iwanaga, Hisamichi Aizawa, Kazunori Oishi   +9 more
openalex   +1 more source

Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective cohort study. [PDF]

Front Public Health
Cossrow N, Bailey MD, Huang YL, Ai L, Mohanty S, McGuinn VC, Johnson KD.   +6 more
europepmc   +1 more source

Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease

, 2006
Leen Moens, Jan Verhaegen, Rajaraman Eri, Séverine Vermeire, K. De Boeck, Willy Peetermans, Xavier Bossuyt   +6 more
openalex   +1 more source

PCV13-Serotype Breakthrough Pneumococcal Disease in Infants Receiving High-Valency Conjugate Vaccines: Population-Level Modeling in France. [PDF]

Infect Dis Ther
Bakker KM, Oidtman RJ, Banniettis N, Feemster K, Velentgas P, Malik TM, Meleleo G, Weaver J.   +7 more
europepmc   +1 more source

Invasive pneumococcal disease in Argentina: a snapshot from a retrospective observational study on serotypes, antimicrobial resistance, and the potential impact of the COVID-19 pandemic (2018-2022). [PDF]

Lancet Reg Health Am
Zintgraff J, Gagetti P, Eluchans NS, Marchetti P, Moscoloni MA, Irazu L, Lara CS, Argentina Spn Working Group, Corso A.   +8 more
europepmc   +1 more source

<i>Streptococcus pneumoniae</i> serotypes and factors associated with antimicrobial resistance in Invasive pneumococcal disease cases in Latvia, 2012-2022. [PDF]

Front Public Health
Savrasova L, Villerusa A, Zeltina I, Krumina A, Cupeca H, Balasegaram S, Greve M, Savicka O, Selderina S, Galajeva J, Dushacka D.   +10 more
europepmc   +1 more source